Form D · Biotechnology
CALVIRI INC
Phoenix, AZ · CIK 0001763612
Offering snapshot reported Nov 12, 2024 · SEC filing
- Reported sold
- $785K Offering amount: $5M
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Oct 24, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 12, 2024 | Initial | $785,004 | No comparison | 10 | SEC filing |
| Sep 24, 2024 | Initial | $150,000 | No comparison | 1 | SEC filing |
| Oct 4, 2023 | Initial | $650,232 | No comparison | 3 | SEC filing |
| May 9, 2023 | Amendment | $11,081,708 | $5,931,705vs Nov 12, 2021 | 32 | SEC filing |
| Nov 12, 2021 | Initial | $5,150,003 | No comparison | 14 | SEC filing |
| Oct 20, 2020 | Initial | $2,430,002 | No comparison | 5 | SEC filing |
| Oct 15, 2020 | Initial | $430,002 | No comparison | 3 | SEC filing |
| Mar 6, 2020 | Amendment | $1,875,000 | $375,000vs Jan 7, 2019 | 4 | SEC filing |
| Jan 7, 2019 | Initial | $1,500,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-529052
Source: Form D, filed Nov 12, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Anna Barker | Director |
| Michael Chambers | Director |
| Stephen Albert Johnston | Director, Executive |
| Jeffrey Le Benger | Director |
| Jeff Le Benger | Director |
| Michael Mc Callister | Director |
| George Poste | Director |
| Jacque J. Sokolov | Director |
| Kathryn Sykes | Director |
| Marc Wolff | Director, Executive |
| Neal Woodbury | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
850 N 5 Th St.
Phoenix, AZ, 85004
Phoenix, AZ, 85004